The Sanofi Ventures-backed vaccine development company has listed on Nasdaq, with its shares rising on the first day of trading.

The ultrasound imaging technology developer backed by multiple corporates has completed a series C round that brought its overall funding to $320m.

Existing investors Pfizer Ventures and Merck GHI helped the precision cancer test developer take its total funding past the $130m mark.

SoftBank-backed barbershop booking service Squire raised $60m at a $750m valuation while card issuing platform developer Lithic was valued at $800m in a round featuring Exor.

Rakuten and SBI have returned to chip into the precision immunotherapy developer’s series D round, which was led by General Catalyst.

SoftBank and Alexandria Real Estate Equities helped the Bloomberg-backed genetic medicine developer raise series C funding to further expand its pipeline of RNA therapies.

MicroPort's implantable implantable defibrillator and pacemaker spinoff has secured funding in a series C round co-led by its parent company.

Carbon-neutral blockchain technology developer Core Scientific raised $54m from Celsius while autoimmune disease therapy developer Topas Therapeutics took a BIVF-backed round past $47m.

SoftBank has contributed to a $350m private placement supporting the health screening provider's reverse takeover.

M Ventures, Novartis Venture Fund and Pfizer Ventures are among the investors backing the DDR cancer therapeutics developer’s latest round, which took its total funding to $320m.